Chronically Administered 3-nitropropionic Acid Induces Striatal Lesions Attributed to Dysfunction of the Blood-brain Barrier
Overview
Authors
Affiliations
3-Nitropropionic acid (3-NPA), an irreversible inhibitor of succinate dehydrogenase, was administered to rats and the characteristics of the neuronal damage were investigated. Injections of 3-NPA (15 mg/kg s.c.) every 2 or 3 days for 1-2 weeks induced a mild neuronal loss and neutrophil invasions in the striatum (STR). The same administration for 4 weeks induced specific symmetric lesions in the lateral STR although the size was variable in each animal. Inside the lesions, strong neutrophil invasions and a strong immunoreaction for IgG, C3 as well as complement factor C3b/C4b receptor (C3b/C4br) were detected. Lesioned sites lost the immunoreaction for GFAP while the marginal areas contained abundant GFAP-labeled astrocytes around the vessels. In intoxicated animals, there was a weak but stout immunoreaction for IgG and C3b/C4br localizing around vessels in the STR even when there were no lesions or neuronal loss. The data suggest that the blood-brain barrier dysfunction is responsible for the specific vulnerability of the STR for the toxin.
Berberine Ameliorate Haloperidol and 3-Nitropropionic Acid-Induced Neurotoxicity in Rats.
Kadir A, Singh J, Rahi V, Kumar P Neurochem Res. 2022; 47(11):3285-3297.
PMID: 35876936 DOI: 10.1007/s11064-022-03677-y.
Huntemann N, Rolfes L, Pawlitzki M, Ruck T, Pfeuffer S, Wiendl H Drugs. 2021; 81(9):1031-1063.
PMID: 34086251 PMC: 8217012. DOI: 10.1007/s40265-021-01526-w.
Basal Mitophagy Occurs Independently of PINK1 in Mouse Tissues of High Metabolic Demand.
McWilliams T, Prescott A, Montava-Garriga L, Ball G, Singh F, Barini E Cell Metab. 2018; 27(2):439-449.e5.
PMID: 29337137 PMC: 5807059. DOI: 10.1016/j.cmet.2017.12.008.
Animal models for glutaryl-CoA dehydrogenase deficiency.
Koeller D, Sauer S, Wajner M, de Mello C, Goodman S, Woontner M J Inherit Metab Dis. 2004; 27(6):813-8.
PMID: 15505386 DOI: 10.1023/B:BOLI.0000045763.52907.5e.
Kim G, Gasche Y, Grzeschik S, Copin J, Maier C, Chan P J Neurosci. 2003; 23(25):8733-42.
PMID: 14507973 PMC: 6740428.